A Master Protocol Study to Investigate Biomarker-guided Novel Anticancer Agent(s) as Monotherapy or Combination Therapy in Participants With Advanced/Recurrent Ovarian Cancer

Clinical trial NCT07060365 · WITHDRAWN

Trial details

NCT number: NCT07060365
Sponsor: AstraZeneca
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced/Recurrent Ovarian Cancer

Start date: 2025-09-02
Primary completion: 2025-12-19
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.